Patents by Inventor Darrin Beaupre

Darrin Beaupre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170354655
    Abstract: Provided are compositions for and methods of treating a B-cell malignancy in a subject in need thereof, by administering to the subject a therapeutically effective amount of a combination comprising an inhibitor of a BTK inhibitor and a TLR inhibitor.
    Type: Application
    Filed: November 17, 2015
    Publication date: December 14, 2017
    Inventors: Darrin Beaupre, Betty Y. Chang, Hsu-Ping Kuo
  • Publication number: 20140243339
    Abstract: This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.
    Type: Application
    Filed: February 28, 2014
    Publication date: August 28, 2014
    Applicant: Amgen Inc.
    Inventors: Teresa L. Burgess, Angela Coxon, Isabelle Dussault, Paula Kaplan-Lefko, Anthony J. Polverino, Darrin Beaupre
  • Publication number: 20110104161
    Abstract: This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by—combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.
    Type: Application
    Filed: May 14, 2009
    Publication date: May 5, 2011
    Inventors: Teresa L. Burgess, Angela Coxon, Isabelle Dussault, Paula Kaplan-Lefko, Anthony J. Polverino, Darrin Beaupre